Managing Heparin Infusions in Patients with Extremes of Weight: Variables to Consider and Practical Implications
ACPE Activity Number:0204-0000-25-045-H01-P Release Date:05/22/2025 Expiration Date:05/22/2028 Activity Type: Knowledge-based CE Credits: 1 contact hour Activity Fee: Member – Free / Non-Member – Not Available
Activity Overview
Dosing heparin infusions in patients with extremes of weight is not as straightforward as dosing in those with normal weights. There are multiple factors to consider when it comes to safety, efficacy, and real-world practice limitations. Join experts as they review heparin dosing strategies, practical and operational considerations, and monitoring parameters.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity was planned to meet the educational needs of pharmacists managing/monitoring heparin infusions in patients with extremes of weight and/or recent use of oral factor Xa inhibitors.
C. Brooke Adams, PharmD, BCOP Clinical Pharmacy Specialist, Malignant Hematology, Stem Cell Transplantation and Cellular Therapy Orlando Health Cancer Institute Orlando, FL
Dustin Bezy, PharmD, BCPS Acute Care Clinical Pharmacist Specialist - Cardiology Banner Heart Hospital Mesa, AZ
Andrew J. Berry, PharmD, BCPS Clinical Pharmacy Program Director Banner Pharmacy Services Phoenix, AZ
Shelbi Adams, Pharm.D., BCPS (Moderator) Clinical Pharmacist St. Elizabeth Healthcare Edgewood, KY
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
